CMS says it will allow insurers to lower premiums for small-group and individual health plans through the end of 2020 "to help ensure that consumers struggling to pay their premiums can continue to be covered and receive the care they may need during" America's coronavirus epidemic, in today's bite-sized hospital and health industry news from Maryland, Mississippi, and New York.
President Trump on Thursday directed the federal government to buy certain prescription drugs and medical supplies exclusively from American factories. The move is aimed at increasing domestic manufacturing and easing shortages—but critics say it could also raise costs.
When a 48-year-old patient with remnants of a brain tumor came to the ED complaining of a headache, Abdul-Kareem Ahmed, a neurosurgery resident at the University of Maryland Medical Center, was confident he knew how to treat it. But after weeks of fruitless treatment, Ahmed would rediscover the need to "listen to our patients," he writes in the Washington Post.
Vaccines are less effective in obese adults than in adults with a lower body mass index, according to research—a disparity that will likely affect vaccines against the novel coronavirus, as well, Sarah Varney writes for Kaiser Health News.
Drugmakers are seeking hundreds of thousands of volunteers to test their experimental candidates for a coronavirus vaccine—but there are a few things people should know before volunteering for a vaccine trial, Heather Murphy writes for the New York Times.
The new coronavirus is far more likely to spread indoors than outdoors, public health experts say. But some businesses are exploring new technologies that could make the indoors safer—and individuals can take steps to lower their risks too, Daily Briefing's Ashley Fuoco Antonelli writes.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.